Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | IKS04 |
| Synonyms | |
| Therapy Description |
IKS04 is an antibody-drug conjugate (ADC) targeting CA242, which potentially inhibits tumor growth (PMID: 41054395). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| IKS04 | IKS-04|IKS 04 | IKS04 is an antibody-drug conjugate (ADC) targeting CA242, which potentially inhibits tumor growth (PMID: 41054395). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07738939 | Phase I | IKS04 | IKS04 Regimen in Advanced Solid Tumors That Express CA242 | Not yet recruiting | USA | 0 |